Panagora Asset Management’s Voyager Therapeutics VYGR Stock Holding History

Panagora Asset Management’s Portfolio VYGR Stock Details VYGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-631	Closed	-$3K	–	2966
2021 Q1	$3K	Hold	631	–	–	﹤0.01%	2678
2020 Q4	$5K	Buy	+631	New	+$6.07K	﹤0.01%	2480
2020 Q2	–	Sell	-579	Closed	-$5K	–	2656
2020 Q1	$5K	Sell	579 -7,731	-93%	-$88.7K	﹤0.01%	2272
2019 Q4	$116K	Buy	8,310 +579	+7%	+$8.42K	﹤0.01%	1767
2019 Q3	$133K	Hold	7,731	–	–	﹤0.01%	1759
2019 Q2	$210K	Buy	+7,731	New	+$177K	﹤0.01%	1778

Other funds holding VYGR

TGI

TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Panagora Asset Management's VYGR Position: Q2 2021 in Review

Panagora Asset Management sold out of Voyager Therapeutics (VYGR) in Q2 2021, closing a stake of 631 shares — an estimated $3K sold.

Panagora Asset Management first reported a position in VYGR in Q2 2019 and held it in 6 quarters. The position peaked at $210K in Q2 2019. 78 funds tracked by Wall St. Rank hold VYGR as of Q2 2021.

Panagora Asset Management reported no remaining Voyager Therapeutics position as of Q2 2021 after selling out during the quarter.
Panagora Asset Management sold 631 Voyager Therapeutics shares in Q2 2021, an estimated $3K.
Panagora Asset Management first reported a position in Voyager Therapeutics in Q2 2019 and held it in 6 quarters.
Panagora Asset Management's Voyager Therapeutics position peaked at $210K in Q2 2019.
78 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2021.

Based on Panagora Asset Management's 13F filing for Q2 2021, filed 11 Aug 2021.